{"recordsFiltered":49216,"recordsTotal":49216,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=sponsor__name&start=47400","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=sponsor__name&start=46800","results":[{"registry_id":"NCT06494111","publication_url":"https://clinicaltrials.gov/study/NCT06494111","title":"Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)","has_exemption":false,"start_date":"2025-02-13","completion_date":"2029-05-01","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06897930","publication_url":"https://clinicaltrials.gov/study/NCT06897930","title":"A Phase 1b/2 Study of AZD0120, a Chimeric Antigen Receptor T-cell (CAR T) Therapy Targeting CD19 and B-cell Maturation Antigen (BCMA) in Subjects With Refractory Systemic Lupus Erythematosus (SLE)","has_exemption":false,"start_date":"2025-04-21","completion_date":"2029-05-01","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06909110","publication_url":"https://clinicaltrials.gov/study/NCT06909110","title":"Viral Specific T-Lymphocytes by Cytokine Capture System (CCS) to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus After Hematopoietic Cell Transplantation or Solid Organ Transplantation and in Patients With Compromised Immunity","has_exemption":false,"start_date":"2025-04-30","completion_date":"2029-05-01","has_results":false,"results_due":false,"sponsor_name":"Jessie L. Alexander","sponsor_slug":"jessie-l-alexander","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06261840","publication_url":"https://clinicaltrials.gov/study/NCT06261840","title":"Refining Treatment Options for Trichomonas Vaginalis Infection in Women and Men: A Comparative Analysis of Oral Multi-Dose Metronidazole and Single-Dose Secnidazole","has_exemption":false,"start_date":"2025-05-06","completion_date":"2029-05-01","has_results":false,"results_due":false,"sponsor_name":"Tulane University","sponsor_slug":"tulane-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06961916","publication_url":"https://clinicaltrials.gov/study/NCT06961916","title":"Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)","has_exemption":false,"start_date":"2025-06-03","completion_date":"2029-05-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06999577","publication_url":"https://clinicaltrials.gov/study/NCT06999577","title":"The MVP Trial: A Randomized Controlled Trial of Mechanism Guided vs PPI Strategy for Laryngopharyngeal Reflux","has_exemption":false,"start_date":"2025-06-04","completion_date":"2029-05-01","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06501820","publication_url":"https://clinicaltrials.gov/study/NCT06501820","title":"Neural Control of Gait & Navigation in ADRD, Aim 3 Clinical Trial","has_exemption":false,"start_date":"2025-11-13","completion_date":"2029-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07024706","publication_url":"https://clinicaltrials.gov/study/NCT07024706","title":"The MAVRiC Study: A Phase II Study of Disease Risk Mutation Guided Finite Duration Acalabrutinib Plus Venetoclax for Relapse in CLL/SLL After First-line Finite Covalent BTKi Plus BCL2i Combination, With or Without Obinutuzumab","has_exemption":false,"start_date":"2026-01-30","completion_date":"2029-05-01","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07530796","publication_url":"https://clinicaltrials.gov/study/NCT07530796","title":"An Open-Label, Single Center, Phase 1/2 Study to Evaluate the Safety and Efficacy of DANAGALEX (scAAV9/AGA) in Participants With Aspartylglucosaminuria (AGU)","has_exemption":false,"start_date":"2026-05-01","completion_date":"2029-05-01","has_results":false,"results_due":false,"sponsor_name":"Rare Trait Hope","sponsor_slug":"rare-trait-hope","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07553975","publication_url":"https://clinicaltrials.gov/study/NCT07553975","title":"Randomized Study Evaluating Cost of Arthrex Nano Arthroscopy Products in Arthroscopic Knee ACL Surgery Versus Conventional Arthroscopy","has_exemption":false,"start_date":"2026-05-01","completion_date":"2029-05-01","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07413939","publication_url":"https://clinicaltrials.gov/study/NCT07413939","title":"A Two-part, Seamless, Multicenter, Randomized, Open-label, Adaptive Phase II/III Study of the Blood-brain Barrier Penetrant RO7771950 Versus Tucatinib, Both in Combination With Trastuzumab and Capecitabine, in Patients With Pretreated Unresectable Locally Advanced or Metastatic HER2-Positive Breast Cancer, With or Without Central Nervous System Metastases","has_exemption":false,"start_date":"2026-05-21","completion_date":"2029-05-01","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07197866","publication_url":"https://clinicaltrials.gov/study/NCT07197866","title":"An Open-Label Extension, Multi-Centered, Phase 2 Trial to Describe the Safety and Efficacy of TEV-56286 (Emrusolmin) in Participants With Multiple System Atrophy","has_exemption":false,"start_date":"2025-09-30","completion_date":"2029-05-03","has_results":false,"results_due":false,"sponsor_name":"Teva Branded Pharmaceutical Products R&D LLC","sponsor_slug":"teva-branded-pharmaceutical-products-rd-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07076121","publication_url":"https://clinicaltrials.gov/study/NCT07076121","title":"A Randomized, Phase 2/3 Study Comparing Navlimetostat (BMS-986504) in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma Harboring Homozygous MTAP Deletion","has_exemption":false,"start_date":"2025-10-23","completion_date":"2029-05-03","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06976476","publication_url":"https://clinicaltrials.gov/study/NCT06976476","title":"Prospective Randomized Phase II Study Evaluating Efficacy and Safety of IgPro20 as Infection Prophylaxis in Patients With Multiple Myeloma and Hypogammaglobulinemia Receiving Therapy With a Bispecific Monoclonal Antibody (BsAbs)","has_exemption":false,"start_date":"2025-05-08","completion_date":"2029-05-08","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06627647","publication_url":"https://clinicaltrials.gov/study/NCT06627647","title":"A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab in Combination With Platinum-based Chemotherapy for the First-line Treatment of Patients With Metastatic Non-squamous Non-small Cell Lung Cancer Whose Tumors Express PD-L1 (ARTEMIDE-Lung03)","has_exemption":false,"start_date":"2024-11-27","completion_date":"2029-05-10","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06630416","publication_url":"https://clinicaltrials.gov/study/NCT06630416","title":"A Phase II Trial to Evaluate Pemetrexed Response in Relation to Tumor Alterations of Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma and Other Solid Tumors","has_exemption":false,"start_date":"2024-11-27","completion_date":"2029-05-10","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07252232","publication_url":"https://clinicaltrials.gov/study/NCT07252232","title":"RASolute 304: A Phase 3 Multicenter, Open-label, Randomized, 2-Arm Study of Adjuvant Daraxonrasib Versus Standard of Care Observation Following Completion of Neoadjuvant and/or Adjuvant Chemotherapy in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)","has_exemption":false,"start_date":"2025-12-15","completion_date":"2029-05-10","has_results":false,"results_due":false,"sponsor_name":"Revolution Medicines, Inc.","sponsor_slug":"revolution-medicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05555732","publication_url":"https://clinicaltrials.gov/study/NCT05555732","title":"A Randomized Phase 3 Study of Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in Subjects With No Prior Therapy for Advanced or Metastatic PD-L1 TPS <50% Non-squamous Non-small Cell Lung Cancer Without Actionable Genomic Alterations (TROPION-Lung07)","has_exemption":false,"start_date":"2023-01-11","completion_date":"2029-05-11","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07184931","publication_url":"https://clinicaltrials.gov/study/NCT07184931","title":"A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Phase 3, Induction Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2025-10-01","completion_date":"2029-05-14","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07201922","publication_url":"https://clinicaltrials.gov/study/NCT07201922","title":"A Double Blind, Randomized, Placebo-controlled Exploratory Trial to Investigate the Efficacy and Safety of Nerandomilast Over 24 Months When Administered in Individuals With Interstitial Lung Abnormalities and a Family History of Pulmonary Fibrosis to Reduce the Risk of Worsening (DROP-FPF)","has_exemption":false,"start_date":"2026-02-10","completion_date":"2029-05-14","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05564390","publication_url":"https://clinicaltrials.gov/study/NCT05564390","title":"Master Screening and Reassessment Protocol (MSRP) for the NCI MyeloMATCH Clinical Trials","has_exemption":false,"start_date":"2024-06-18","completion_date":"2029-05-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06317649","publication_url":"https://clinicaltrials.gov/study/NCT06317649","title":"A Randomized Phase II Study of Venetoclax and HMA-Based Therapies for the Treatment of Older and Unfit Adults With Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML): A MyeloMATCH Treatment Trial","has_exemption":false,"start_date":"2024-09-27","completion_date":"2029-05-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07524257","publication_url":"https://clinicaltrials.gov/study/NCT07524257","title":"Phase 3, Randomized, Open-Label Study of Nogapendekin Alfa Inbakicept in Combination With Standard of Care Versus Standard of Care as First-Line Treatment for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2026-05-29","completion_date":"2029-05-15","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05458297","publication_url":"https://clinicaltrials.gov/study/NCT05458297","title":"A Multicenter, Open-label, Phase 2 Basket Study to Evaluate the Safety and Efficacy of MK-2140 as a Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (waveLINE-006)","has_exemption":false,"start_date":"2022-07-21","completion_date":"2029-05-17","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05878717","publication_url":"https://clinicaltrials.gov/study/NCT05878717","title":"A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy And Safety of Belimumab Administered Subcutaneously in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (SSC-ILD)","has_exemption":false,"start_date":"2023-09-13","completion_date":"2029-05-17","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06662448","publication_url":"https://clinicaltrials.gov/study/NCT06662448","title":"An Open-Label Study to Evaluate the Efficacy and Feasibility of Home-Based Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies","has_exemption":false,"start_date":"2024-11-18","completion_date":"2029-05-18","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06430788","publication_url":"https://clinicaltrials.gov/study/NCT06430788","title":"Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia","has_exemption":false,"start_date":"2024-05-21","completion_date":"2029-05-21","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07006506","publication_url":"https://clinicaltrials.gov/study/NCT07006506","title":"Phase II Open Label Prospective Nonrandomized Trial of Belumosudil for Switch-Maintenance Prophylaxis of Graft-versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2025-05-21","completion_date":"2029-05-21","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07222761","publication_url":"https://clinicaltrials.gov/study/NCT07222761","title":"An Open-Label, Randomized Phase 3 Study of Linvoseltamab Monotherapy and Linvoseltamab Plus Carfilzomib Versus Standard of Care Combination Regimens in Patients With Relapsed/Refractory Multiple Myeloma","has_exemption":false,"start_date":"2026-01-02","completion_date":"2029-05-21","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05485961","publication_url":"https://clinicaltrials.gov/study/NCT05485961","title":"A Phase 2b / 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects With End Stage Kidney Disease Undergoing Dialysis","has_exemption":false,"start_date":"2022-10-21","completion_date":"2029-05-22","has_results":false,"results_due":false,"sponsor_name":"CSL Behring","sponsor_slug":"csl-behring","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06667076","publication_url":"https://clinicaltrials.gov/study/NCT06667076","title":"A Phase 2b, Open-Label, Two-cohort Study of Subcutaneous Amivantamab in Combination With Lazertinib as First-Line Treatment, or Subcutaneous Amivantamab in Combination With Platinum-Based Chemotherapy as Second-line Treatment, for Common EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2024-12-16","completion_date":"2029-05-23","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07525375","publication_url":"https://clinicaltrials.gov/study/NCT07525375","title":"A Phase II, Randomized, Double-blind, 3-Period Cross-over, Dose-ranging Study to Assess the Efficacy and Safety of Glycopyrronium (GP) Versus Placebo in Participants of 4 to Less Than 12 Years of Age With Asthma Receiving Background Budesonide and Formoterol Fumarate (BFF)","has_exemption":false,"start_date":"2026-04-14","completion_date":"2029-05-23","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07203001","publication_url":"https://clinicaltrials.gov/study/NCT07203001","title":"An Open-label Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease","has_exemption":false,"start_date":"2025-11-03","completion_date":"2029-05-24","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07332481","publication_url":"https://clinicaltrials.gov/study/NCT07332481","title":"A Phase 3, Randomized, Double-Blind,Placebo-Controlled Parallel Study to Evaluate the Efficacy and Safety of Enpatoran in Participants With Active Cutaneous Manifestations of Lupus Erythematosus With or Without Systemic Disease Receiving Standard of Care (ELOWEN-1)","has_exemption":false,"start_date":"2026-03-10","completion_date":"2029-05-24","has_results":false,"results_due":false,"sponsor_name":"EMD Serono Research & Development Institute, Inc.","sponsor_slug":"emd-serono-research-development-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03965234","publication_url":"https://clinicaltrials.gov/study/NCT03965234","title":"Phase I/ II Study of Pulmonary Suffusion to Control Minimal Residual Disease in Resectable or Ablatable Sarcoma or Colorectal Pulmonary Metastases","has_exemption":false,"start_date":"2020-07-16","completion_date":"2029-05-25","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05285826","publication_url":"https://clinicaltrials.gov/study/NCT05285826","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy, Immunogenicity, and Safety of V503, a 9-Valent Human Papillomavirus (HPV) Vaccine, in Chinese Males 20 to 45 Years of Age","has_exemption":false,"start_date":"2022-02-18","completion_date":"2029-05-25","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07355218","publication_url":"https://clinicaltrials.gov/study/NCT07355218","title":"A Phase 3, Randomized, Double-Blind,Placebo-Controlled Parallel Study to Evaluate the Efficacy and Safety of Enpatoran in Participants With Active Cutaneous Manifestations of Lupus Erythematosus With or Without Systemic Disease Receiving Standard of Care (ELOWEN-2)","has_exemption":false,"start_date":"2026-04-01","completion_date":"2029-05-25","has_results":false,"results_due":false,"sponsor_name":"EMD Serono Research & Development Institute, Inc.","sponsor_slug":"emd-serono-research-development-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07631000","publication_url":"https://clinicaltrials.gov/study/NCT07631000","title":"A Phase 2, Single-arm Study of Cadonilimab and FLOT Chemotherapy in Patients With Locally Advanced, Resectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma","has_exemption":false,"start_date":"2026-05-27","completion_date":"2029-05-27","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287982","publication_url":"https://clinicaltrials.gov/study/NCT07287982","title":"A Phase 2 Double-Blinded, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy","has_exemption":false,"start_date":"2025-12-19","completion_date":"2029-05-28","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03307980","publication_url":"https://clinicaltrials.gov/study/NCT03307980","title":"A FACTOR IX (FIX) GENE TRANSFER, MULTI CENTER EVALUATION OF THE LONG TERM SAFETY AND EFFICACY STUDY OF PF 06838435 AND A DOSE ESCALATION SUBSTUDY IN INDIVIDUALS WITH HEMOPHILIA B","has_exemption":false,"start_date":"2017-06-22","completion_date":"2029-05-29","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04776252","publication_url":"https://clinicaltrials.gov/study/NCT04776252","title":"A Phase 3 Open-label Rollover Clinical Study of Doravirine/Islatravir (DOR/ISL) Once-daily for the Treatment of HIV-1 Infection in Participants Who Previously Received DOR/ISL in a Phase 2 or Phase 3 DOR/ISL Clinical Study","has_exemption":false,"start_date":"2021-09-15","completion_date":"2029-05-29","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04802759","publication_url":"https://clinicaltrials.gov/study/NCT04802759","title":"A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Breast Cancer (MORPHEUS-BREAST CANCER)","has_exemption":false,"start_date":"2021-06-22","completion_date":"2029-05-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04669171","publication_url":"https://clinicaltrials.gov/study/NCT04669171","title":"A Global Multicenter Phase 1/2 Trial of EO2463, a Novel Microbial-Derived Peptide Therapeutic Vaccine, as Monotherapy, and in Combination With Lenalidomide and Rituximab, for Treatment of Patients With Indolent Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2021-07-05","completion_date":"2029-05-30","has_results":false,"results_due":false,"sponsor_name":"Enterome","sponsor_slug":"enterome","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06599099","publication_url":"https://clinicaltrials.gov/study/NCT06599099","title":"Building Mood State Classifiers to Inform Deep Brain Stimulation of Treatment-Resistant Bipolar Depression","has_exemption":false,"start_date":"2025-01-01","completion_date":"2029-05-30","has_results":false,"results_due":false,"sponsor_name":"Wayne Goodman MD","sponsor_slug":"wayne-goodman-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07592611","publication_url":"https://clinicaltrials.gov/study/NCT07592611","title":"Deep Brain Stimulation in Treatment Resistant Schizophrenia","has_exemption":false,"start_date":"2026-08-01","completion_date":"2029-05-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03705585","publication_url":"https://clinicaltrials.gov/study/NCT03705585","title":"CVD 38000: Immunity, Microbiome, Epigenetics, and a Systems Biology Approach to the Study of Responses to Vaccination With Typhoid and/or Cholera","has_exemption":false,"start_date":"2018-11-05","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04339764","publication_url":"https://clinicaltrials.gov/study/NCT04339764","title":"A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration","has_exemption":false,"start_date":"2020-09-23","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"National Eye Institute (NEI)","sponsor_slug":"national-eye-institute-nei","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05318573","publication_url":"https://clinicaltrials.gov/study/NCT05318573","title":"A Phase 2a Study With Safety Run-in to Evaluate the Safety, Tolerability, and Preliminary Efficacy of FF-10832 Monotherapy or in Combination With Pembrolizumab in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-06-01","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Fujifilm Pharmaceuticals U.S.A., Inc.","sponsor_slug":"fujifilm-pharmaceuticals-usa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06016842","publication_url":"https://clinicaltrials.gov/study/NCT06016842","title":"A Phase III Randomised, Parallel-Group, Double-Blind, Placebo-Controlled, Two-Arm Study to Evaluate the Efficacy and Safety of Elafibranor 80 mg on Long-Term Clinical Outcomes in Adult Participants With Primary Biliary Cholangitis (PBC)","has_exemption":false,"start_date":"2023-08-31","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Ipsen","sponsor_slug":"ipsen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05537220","publication_url":"https://clinicaltrials.gov/study/NCT05537220","title":"NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa","has_exemption":false,"start_date":"2023-10-11","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05890729","publication_url":"https://clinicaltrials.gov/study/NCT05890729","title":"A Seamless, Phase 1b/2 Multiple Ascending Dose/Proof of Concept Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations","has_exemption":false,"start_date":"2023-11-10","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Xentria, Inc.","sponsor_slug":"xentria-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06420297","publication_url":"https://clinicaltrials.gov/study/NCT06420297","title":"A Long-term, Open-label Extension Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome","has_exemption":false,"start_date":"2024-03-11","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"ACADIA Pharmaceuticals Inc.","sponsor_slug":"acadia-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05940207","publication_url":"https://clinicaltrials.gov/study/NCT05940207","title":"Safety Testing of Hydrogen Peroxide-Generating e-Bandage on Normal Human Skin","has_exemption":false,"start_date":"2024-03-27","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06545136","publication_url":"https://clinicaltrials.gov/study/NCT06545136","title":"A Multicenter, Long-term, Follow-up Study to Investigate the Safety and Durability of Response Following Dosing of an Adeno-associated Viral Vector (FLT201) in Subjects With Gaucher Disease (GALILEO-2)","has_exemption":false,"start_date":"2024-05-13","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Spur Therapeutics","sponsor_slug":"spur-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06295731","publication_url":"https://clinicaltrials.gov/study/NCT06295731","title":"A Phase 2/3, Randomized Study of INBRX-106 Combined With Pembrolizumab Versus Pembrolizumab as First Line Treatment for Patients With Recurrent or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) Expressing PD-L1 (CPS ≥20) (HexAgon-HN)","has_exemption":false,"start_date":"2024-05-14","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Inhibrx Biosciences, Inc","sponsor_slug":"inhibrx-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06374875","publication_url":"https://clinicaltrials.gov/study/NCT06374875","title":"A Prospective Multicenter International Randomized Controlled Trial Comparing Surgical and Medical Therapies in the Treatment of Advanced Metabolic Dysfunction Associated Steatohepatitis","has_exemption":false,"start_date":"2024-07-11","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Ali Aminian","sponsor_slug":"ali-aminian","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06485206","publication_url":"https://clinicaltrials.gov/study/NCT06485206","title":"A Clinical Investigation Evaluating Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.","has_exemption":false,"start_date":"2024-09-01","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Highridge Medical","sponsor_slug":"highridge-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06789848","publication_url":"https://clinicaltrials.gov/study/NCT06789848","title":"Phase II Basket Trial of Ligufalimab (AK117) and Cadonilimab (AK104) in Advanced Hepatobiliary Cancers","has_exemption":false,"start_date":"2025-02-18","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06682442","publication_url":"https://clinicaltrials.gov/study/NCT06682442","title":"Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma","has_exemption":false,"start_date":"2025-03-18","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06604520","publication_url":"https://clinicaltrials.gov/study/NCT06604520","title":"Functional Neuroimaging to Examine Affective Symptoms and Cognition in Frontotemporal Dementia","has_exemption":false,"start_date":"2025-03-20","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06907290","publication_url":"https://clinicaltrials.gov/study/NCT06907290","title":"A Global, Randomized, Open-label, Multicenter, Phase 2b/3 Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-1)","has_exemption":false,"start_date":"2025-03-25","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Mirum Pharmaceuticals, Inc.","sponsor_slug":"mirum-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06890598","publication_url":"https://clinicaltrials.gov/study/NCT06890598","title":"A Phase 3, Multicenter, Double-Blind, Placebo-controlled Study Assessing the Efficacy and Safety of Olomorasib in Combination With Standard of Care Immunotherapy in Participants With Resected or Unresectable KRAS G12C-Mutant, Non-Small Cell Lung Cancer - SUNRAY-02","has_exemption":false,"start_date":"2025-03-27","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06966401","publication_url":"https://clinicaltrials.gov/study/NCT06966401","title":"A Long-Term, Open-Label Study to Assess the Safety and Tolerability of NBI-1065845 as Adjunctive Treatment in Subjects With Major Depressive Disorder (MDD)","has_exemption":false,"start_date":"2025-04-16","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Neurocrine Biosciences","sponsor_slug":"neurocrine-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06768905","publication_url":"https://clinicaltrials.gov/study/NCT06768905","title":"IOMAB-ACT: A Phase Ib/II Multi-institutional Study of 131 I-Apamistamab Followed by CD19-Targeted CAR-T Cell Therapy for Patients With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)","has_exemption":false,"start_date":"2025-04-25","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06812715","publication_url":"https://clinicaltrials.gov/study/NCT06812715","title":"Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib","has_exemption":false,"start_date":"2025-05-05","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Peter MacCallum Cancer Centre, Australia","sponsor_slug":"peter-maccallum-cancer-centre-australia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06512194","publication_url":"https://clinicaltrials.gov/study/NCT06512194","title":"An Investigation of Strategies to Understand and Optimize the Antidepressant Effects of Psilocybin (The OPTIMIZE Study)","has_exemption":false,"start_date":"2025-05-13","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Charles Raison","sponsor_slug":"charles-raison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07059065","publication_url":"https://clinicaltrials.gov/study/NCT07059065","title":"A Post-market, Prospective, Controlled, Multicenter Clinical Study to Evaluate Radiographic Fusion of FIBERGRAFT™ Aeridyan Matrix Bone Graft Substitute in Subjects Who Undergo a Lumbar Posterolateral Fusion Surgery","has_exemption":false,"start_date":"2025-08-15","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"DePuy Synthes Products, Inc.","sponsor_slug":"depuy-synthes-products-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06349083","publication_url":"https://clinicaltrials.gov/study/NCT06349083","title":"Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use Disorder","has_exemption":false,"start_date":"2025-08-26","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06899165","publication_url":"https://clinicaltrials.gov/study/NCT06899165","title":"Processing Intergenerational Trauma With Psilocybin-Assisted Therapy","has_exemption":false,"start_date":"2025-08-28","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Rachel Yehuda","sponsor_slug":"rachel-yehuda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07174583","publication_url":"https://clinicaltrials.gov/study/NCT07174583","title":"A Multicenter Study Evaluating the Safety, Efficacy, and Pharmacokinetics of IDE849 in Patients With DLL3-Expressing Tumors Including Small Cell Lung Cancer","has_exemption":false,"start_date":"2025-10-14","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"IDEAYA Biosciences","sponsor_slug":"ideaya-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218796","publication_url":"https://clinicaltrials.gov/study/NCT07218796","title":"A Prospective, Multicenter, Randomized, Masked, Controlled Study to Evaluate the Safety and Efficacy of the Bimatoprost Implant System (78 mcg) Used in Combination With the SpyGlass IOL Compared to Timolol Maleate Ophthalmic Solution, USP, 0.5%,","has_exemption":false,"start_date":"2025-10-28","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"SpyGlass Pharma, Inc.","sponsor_slug":"spyglass-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07155174","publication_url":"https://clinicaltrials.gov/study/NCT07155174","title":"A Phase 2 Randomized, Open Label, Multicenter Study to Evaluate the Optimal Dose, Safety, and Efficacy of ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Subjects With Previously Untreated Extensive Stage Small Cell Lung Cancer (ES-SCLC)","has_exemption":false,"start_date":"2025-11-25","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06961357","publication_url":"https://clinicaltrials.gov/study/NCT06961357","title":"Phase I/II Clinical Trial of CD40L-augmented Tumor Infiltrating Lymphocytes (TIL) for Patients With Advanced Melanoma","has_exemption":false,"start_date":"2025-12-03","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07174336","publication_url":"https://clinicaltrials.gov/study/NCT07174336","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY4064809 Combined With a CDK4/6 Inhibitor and Endocrine Therapy in Adults With HR+, HER2-Advanced Breast Cancer With a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)","has_exemption":false,"start_date":"2025-12-22","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285694","publication_url":"https://clinicaltrials.gov/study/NCT07285694","title":"An Open-label, Multicenter Phase 1/2 Study to Evaluate the Safety and Efficacy of AB-3028 in Patients With Castration Resistant Prostate Cancer (CRPC)","has_exemption":false,"start_date":"2026-01-09","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Arsenal Biosciences, Inc.","sponsor_slug":"arsenal-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06954129","publication_url":"https://clinicaltrials.gov/study/NCT06954129","title":"Markers of Nephrotoxicity During Treatment With Antibiotic Combinations: A Pragmatic Clinical Trial","has_exemption":false,"start_date":"2026-01-28","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06875128","publication_url":"https://clinicaltrials.gov/study/NCT06875128","title":"An Open-label, Randomized, Multi-Center Study to Evaluate the Efficacy and Safety of Induction Treatment With Melphalan/HDS Followed by Consolidation Treatment With Eribulin or Vinorelbine or Capecitabine Versus Eribulin or Vinorelbine or Capecitabine Alone in Patients With Metastatic Breast Cancer With Liver Dominant Disease","has_exemption":false,"start_date":"2026-01-29","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Delcath Systems Inc.","sponsor_slug":"delcath-systems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07397338","publication_url":"https://clinicaltrials.gov/study/NCT07397338","title":"A Phase 1/2 Open-Label, Multicenter Study of RAS(ON) Inhibitors in Combination With Ivonescimab With or Without Other Anti-Cancer Agents in Patients With Solid Tumors","has_exemption":false,"start_date":"2026-01-30","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Revolution Medicines, Inc.","sponsor_slug":"revolution-medicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07436156","publication_url":"https://clinicaltrials.gov/study/NCT07436156","title":"SUMMIT RISE Study of Acute Ischemic Stroke Patients Evaluating the Route 92 Medical Reperfusion Systems.","has_exemption":false,"start_date":"2026-02-12","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Route 92 Medical, Inc.","sponsor_slug":"route-92-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07491497","publication_url":"https://clinicaltrials.gov/study/NCT07491497","title":"A Phase 1/2, Dose Escalation and Expansion Study of TRI-611, an Oral ALK Molecular Glue Degrader in Participants With Advanced ALK-Positive NSCLC","has_exemption":false,"start_date":"2026-03-11","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"TRIANA Biomedicines, Inc.","sponsor_slug":"triana-biomedicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07504796","publication_url":"https://clinicaltrials.gov/study/NCT07504796","title":"A Multi-center Trial Evaluating the ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab for Advanced Melanoma","has_exemption":false,"start_date":"2026-04-13","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07558733","publication_url":"https://clinicaltrials.gov/study/NCT07558733","title":"Open-Label Umbrella Study to Evaluate Safety and Efficacy of Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced or Metastatic Breast Cancer","has_exemption":false,"start_date":"2026-04-30","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Faeth Therapeutics","sponsor_slug":"faeth-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07424092","publication_url":"https://clinicaltrials.gov/study/NCT07424092","title":"Intratumoral DNX-2401 Administration for Recurrent and Refractory High Grade Brain Tumors in Pediatric and Young Adult Patients","has_exemption":false,"start_date":"2026-05-12","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Clinica Universidad de Navarra, Universidad de Navarra","sponsor_slug":"clinica-universidad-de-navarra-universidad-de-navarra","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07612215","publication_url":"https://clinicaltrials.gov/study/NCT07612215","title":"Elacestrant in Advanced Triple Positive Breast Cancer, a Phase II Evaluation (ELATE)","has_exemption":false,"start_date":"2026-05-13","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06773936","publication_url":"https://clinicaltrials.gov/study/NCT06773936","title":"A Phase II Trial of Asciminib, Dasatinib, Prednisone, and Blinatumomab for Participants With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia","has_exemption":false,"start_date":"2026-05-15","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07525206","publication_url":"https://clinicaltrials.gov/study/NCT07525206","title":"An Open-Label, Randomized, Controlled, Global Phase 3 Study Comparing Telisotuzumab Adizutecan (ABBV-400) Plus Bevacizumab to LONSURF (Trifluridine and Tipiracil) Plus Bevacizumab in Subjects With Refractory Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2026-05-22","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07574632","publication_url":"https://clinicaltrials.gov/study/NCT07574632","title":"The RESILIENT Scoliosis Brace System Clinical Trial (RESILIENT)","has_exemption":false,"start_date":"2026-05-28","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Thinks Works, PBC","sponsor_slug":"thinks-works-pbc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07392957","publication_url":"https://clinicaltrials.gov/study/NCT07392957","title":"A Phase IB/II Open-label Study of the Safety and Preliminary Efficacy of CTX-009 Administered Either as a Monotherapy or in Combination With CTX-471 in Patients With Recurrent Glioblastoma","has_exemption":false,"start_date":"2026-05-31","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07472439","publication_url":"https://clinicaltrials.gov/study/NCT07472439","title":"Randomized Controlled Trial of the Auryon Atherectomy System Used in Combination With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone Treating Infrapopliteal Lesions in Subjects With Critical Limb Ischemia","has_exemption":false,"start_date":"2026-05-31","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Angiodynamics, Inc.","sponsor_slug":"angiodynamics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07566234","publication_url":"https://clinicaltrials.gov/study/NCT07566234","title":"Myopia Prevention Study in Chinese Population With Dual Focus Myopia Control Lenses.","has_exemption":false,"start_date":"2026-05-31","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"CooperVision International Limited (CVIL)","sponsor_slug":"coopervision-international-limited-cvil","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07071935","publication_url":"https://clinicaltrials.gov/study/NCT07071935","title":"A Pilot Randomized Clinical Trial of Early Ventilation in Amyotrophic Lateral Sclerosis (EVENT ALS)","has_exemption":false,"start_date":"2026-06-11","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07501078","publication_url":"https://clinicaltrials.gov/study/NCT07501078","title":"Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Muhammad N Aslam, MD","sponsor_slug":"muhammad-n-aslam-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07573540","publication_url":"https://clinicaltrials.gov/study/NCT07573540","title":"Optimizing Algorithmic Feedback About Lapse Risk for Trust, Engagement, and Clinical Outcomes for Alcohol Use Disorder","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07587242","publication_url":"https://clinicaltrials.gov/study/NCT07587242","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study With an Open-Label Extension to Evaluate the Efficacy and Safety of Intravenous AOC 1044 (Delpacibart Zotadirsen) for the Treatment of DMD With Gene Mutations Amenable to Exon 44 Skipping","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Avidity Biosciences, Inc.","sponsor_slug":"avidity-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07631572","publication_url":"https://clinicaltrials.gov/study/NCT07631572","title":"Phase II Clinical Trial of Cesium-131 Low-dose Rate Interstitial Brachytherapy as an Organ-preserving Irradiation Technique for Recurrent Cervical and Endometrial Cancer","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Denise Fabian","sponsor_slug":"denise-fabian","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07021989","publication_url":"https://clinicaltrials.gov/study/NCT07021989","title":"Pembrolizumab and GVD With ctDNA-guided Consolidation in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma: A Multicenter Phase 2 Study of the University of California Hematologic Malignancies Consortium","has_exemption":false,"start_date":"2026-07-01","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Michael Spinner, MD","sponsor_slug":"michael-spinner-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06935474","publication_url":"https://clinicaltrials.gov/study/NCT06935474","title":"Multi-center, Phase 1/2 Study of an Autologous Anti-CD20/BCMA CAR T Cell Therapy (C-CAR168) for the Treatment of Autoimmune Disease Refractory to Standard Therapy","has_exemption":false,"start_date":"2026-07-31","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"AbelZeta, Inc.","sponsor_slug":"abelzeta-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07592910","publication_url":"https://clinicaltrials.gov/study/NCT07592910","title":"A Phase 2, Open-label, Single-Arm Study of Mevrometostat Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Following Prior Androgen Receptor Pathway Inhibitor Therapy (MOMENT)","has_exemption":false,"start_date":"2026-08-31","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Prostate Cancer Clinical Trials Consortium","sponsor_slug":"prostate-cancer-clinical-trials-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07608718","publication_url":"https://clinicaltrials.gov/study/NCT07608718","title":"A Single Arm Phase II Trial of Zanzalitinib in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) With Soft Tissue or Visceral Metastases","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Pedro Barata, MD, MSc","sponsor_slug":"pedro-barata-md-msc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07538609","publication_url":"https://clinicaltrials.gov/study/NCT07538609","title":"The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study","has_exemption":false,"start_date":"2026-10-07","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"W.L.Gore & Associates","sponsor_slug":"wlgore-associates","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07437950","publication_url":"https://clinicaltrials.gov/study/NCT07437950","title":"A Randomized Phase II Trial of ASTX727 With Standard Duration Versus Shorter Duration of Venetoclax in Genomically Heterogenous AML Among Adults Aged 60 or Older and Less Fit for Intensive Therapy: A MyeloMATCH Substudy","has_exemption":false,"start_date":"2026-10-14","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07639684","publication_url":"https://clinicaltrials.gov/study/NCT07639684","title":"Metabolic Effects of Endoscopic Sleeve Gastroplasty in Obese Adults With Type 2 Diabetes: Evaluation of Glycemic Control, Insulin Use and Obesity Response","has_exemption":false,"start_date":"2027-02-28","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Boston Scientific Corporation","sponsor_slug":"boston-scientific-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06769854","publication_url":"https://clinicaltrials.gov/study/NCT06769854","title":"Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children","has_exemption":false,"start_date":"2027-04-01","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Chi Dang Hornik","sponsor_slug":"chi-dang-hornik","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06816433","publication_url":"https://clinicaltrials.gov/study/NCT06816433","title":"A Phase 2, Multi-center, Multi-arm, Randomized, Placebo-controlled, Double-blind, Adaptive Platform Study to Evaluate the Safety, Tolerability, and Efficacy of Potential Pharmacotherapeutic Interventions in Active-Duty Service Members, Veterans, and Non-Veteran Civilians With PTSD","has_exemption":false,"start_date":"2028-05-31","completion_date":"2029-05-31","has_results":false,"results_due":false,"sponsor_name":"Global Coalition for Adaptive Research","sponsor_slug":"global-coalition-for-adaptive-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03258567","publication_url":"https://clinicaltrials.gov/study/NCT03258567","title":"Phase 2 Trial of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas","has_exemption":false,"start_date":"2018-04-26","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06548061","publication_url":"https://clinicaltrials.gov/study/NCT06548061","title":"Single Center Observational Study Using Spinal Laser Interstitial Thermal Therapy (sLITT) in the Treatment of Spine Metastases and Tumors","has_exemption":false,"start_date":"2024-05-16","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06978088","publication_url":"https://clinicaltrials.gov/study/NCT06978088","title":"A Multicenter Parallel 2 Cohort Phase 2 Study of LP-168 and Obinutuzumab for Previously Treated, and T474 Gatekeeper Mutant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This","has_exemption":false,"start_date":"2025-06-01","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Zulfa Omer","sponsor_slug":"zulfa-omer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07129993","publication_url":"https://clinicaltrials.gov/study/NCT07129993","title":"A Randomized, Open-Label, Phase 2/3 Study of Datopotamab Deruxtecan (Dato-DXd) Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC) Who Progressed During or After Enfortumab Vedotin (EV) Plus Pembrolizumab Combination Treatment TROPION-Urothelial03 (TU03)","has_exemption":false,"start_date":"2025-09-26","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06816927","publication_url":"https://clinicaltrials.gov/study/NCT06816927","title":"A Multi-Center, Randomized, Phase 2 Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab (GIANT)","has_exemption":false,"start_date":"2025-11-28","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06944145","publication_url":"https://clinicaltrials.gov/study/NCT06944145","title":"A Phase 2b Randomized, Single-Center, Double Blind, Placebo Controlled, 2-Arm Study to Investigate Orally Administered Combination Therapies (5-alpha Reductase Inhibitor + Raloxifene) Compared With Monotherapy (5-alpha Reductase Inhibitor + Placebo) in Adult Patients With Benign Prostatic Hyperplasia (BPH)","has_exemption":false,"start_date":"2025-12-03","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05899764","publication_url":"https://clinicaltrials.gov/study/NCT05899764","title":"Epileptic Hippocampus in Alzheimer's Disease","has_exemption":false,"start_date":"2026-01-01","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07541209","publication_url":"https://clinicaltrials.gov/study/NCT07541209","title":"A Phase 1/2 Open-label First-in-Human Dose-Escalating Safety and Efficacy Study Evaluating Subcutaneous Administration of PTH-IA in Adults and Children With Jansen s Metaphyseal Chondrodysplasia (JMC)","has_exemption":false,"start_date":"2026-05-27","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Dental and Craniofacial Research (NIDCR)","sponsor_slug":"national-institute-of-dental-and-craniofacial-research-nidcr","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07099638","publication_url":"https://clinicaltrials.gov/study/NCT07099638","title":"Randomized Factorial Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention to Promote Smoking Cessation","has_exemption":false,"start_date":"2026-05-31","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07361484","publication_url":"https://clinicaltrials.gov/study/NCT07361484","title":"A Global, Multicenter, Randomized, Double-blinded, Phase 3 Study of Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer With EGFR, ALK, ROS, and RET Wild Type After Progressing on Prior Immunotherapy (Anti-PD-1/L1 Antibody) and Platinum-based Chemotherapy (DUBLIN-4)","has_exemption":false,"start_date":"2026-06-01","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"BeyondSpring Pharmaceuticals Inc.","sponsor_slug":"beyondspring-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07543172","publication_url":"https://clinicaltrials.gov/study/NCT07543172","title":"Phase II Study of CIMAVAX-EGF in Combination With KRAS G12C Inhibitors as Treatment for Advanced Stage KRAS G12C Mutated NSCLC","has_exemption":false,"start_date":"2026-06-01","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06863402","publication_url":"https://clinicaltrials.gov/study/NCT06863402","title":"Nemtabrutinib and Pembrolizumab in Patients With Richter Transformation: A Phase II Study","has_exemption":false,"start_date":"2026-06-15","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07466498","publication_url":"https://clinicaltrials.gov/study/NCT07466498","title":"Estrogen for Quality-of-Life and Immune Modulation in Prostate Cancer (EQUIP)","has_exemption":false,"start_date":"2026-08-01","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07578649","publication_url":"https://clinicaltrials.gov/study/NCT07578649","title":"AN INTERVENTIONAL PHASE 3, OPEN LABEL, RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH ADVANCED OR RECURRENT MISMATCH REPAIR PROFICIENT ENDOMETRIAL CANCER","has_exemption":false,"start_date":"2026-10-09","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06448286","publication_url":"https://clinicaltrials.gov/study/NCT06448286","title":"PH Weighted Chemical Exchange Saturation Transfer Based Surgical Resections of Glioblastoma","has_exemption":false,"start_date":"2026-12-01","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07229339","publication_url":"https://clinicaltrials.gov/study/NCT07229339","title":"Phase 2 Trial of Zipalertinib in Patients With Resectable Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion or Uncommon/Compound Mutations","has_exemption":false,"start_date":"2027-06-01","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Jonsson Comprehensive Cancer Center","sponsor_slug":"jonsson-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07430332","publication_url":"https://clinicaltrials.gov/study/NCT07430332","title":"Leveraging Semaglutide for Preservation of Beta Cell Function and Restoration of Alpha Cell Function","has_exemption":false,"start_date":"2027-09-01","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011758","publication_url":"https://clinicaltrials.gov/study/NCT07011758","title":"Dynamic Treatment Regimes for Personalized Opioid Use Disorder Care","has_exemption":false,"start_date":"2028-07-01","completion_date":"2029-06-01","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06900595","publication_url":"https://clinicaltrials.gov/study/NCT06900595","title":"A Phase II Study of Cabozantinib in Combination With Cemiplimab (Cabo-Cemiplimab) Versus Cabozantinib Alone in Adolescents and Adults With Advanced Adrenocortical Cancer","has_exemption":false,"start_date":"2026-02-22","completion_date":"2029-06-02","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07286214","publication_url":"https://clinicaltrials.gov/study/NCT07286214","title":"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Each of Two Dose Levels of Sarilumab in Adults With Early Polymyalgia Rheumatica","has_exemption":false,"start_date":"2026-05-12","completion_date":"2029-06-04","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06632457","publication_url":"https://clinicaltrials.gov/study/NCT06632457","title":"A Phase III Double-blind, Randomised, Placebo-controlled Trial to Evaluate Liver-related Clinical Outcomes and Safety of Once Weekly Injected Survodutide in Participants With Compensated Non-alcoholic Steatohepatitis/Metabolic Dysfunction Associated Steatohepatitis (NASH/MASH) Cirrhosis","has_exemption":false,"start_date":"2024-11-07","completion_date":"2029-06-05","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07629440","publication_url":"https://clinicaltrials.gov/study/NCT07629440","title":"A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS","has_exemption":false,"start_date":"2026-05-29","completion_date":"2029-06-05","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07595042","publication_url":"https://clinicaltrials.gov/study/NCT07595042","title":"A Phase 2C Trial of Stratified Patient-Centered Treatment Regimens for Active TB","has_exemption":false,"start_date":"2026-07-31","completion_date":"2029-06-05","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06868290","publication_url":"https://clinicaltrials.gov/study/NCT06868290","title":"A Phase 2, Randomized, Open-label, Controlled Study to Evaluate the Efficacy and Safety of Rapcabtagene Autoleucel Versus Comparator in Participants With Severe Active Granulomatosis With Polyangiitis (GPA) or Microscopic Polyangiitis (MPA)","has_exemption":false,"start_date":"2025-03-13","completion_date":"2029-06-07","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07218510","publication_url":"https://clinicaltrials.gov/study/NCT07218510","title":"A Phase 2 Study of Venetoclax + Obinutuzumab Followed by Epcoritamab in Previously Untreated Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (LonGEVity)","has_exemption":false,"start_date":"2026-01-07","completion_date":"2029-06-08","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07084584","publication_url":"https://clinicaltrials.gov/study/NCT07084584","title":"A Phase 1/2, Open-label, Dose-Escalation and Dose-Expansion Cohort Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia","has_exemption":false,"start_date":"2026-06-10","completion_date":"2029-06-10","has_results":false,"results_due":false,"sponsor_name":"Galecto Biotech AB","sponsor_slug":"galecto-biotech-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727773","publication_url":"https://clinicaltrials.gov/study/NCT06727773","title":"Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer","has_exemption":false,"start_date":"2025-08-19","completion_date":"2029-06-15","has_results":false,"results_due":false,"sponsor_name":"UNC Lineberger Comprehensive Cancer Center","sponsor_slug":"unc-lineberger-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07623200","publication_url":"https://clinicaltrials.gov/study/NCT07623200","title":"A Phase 3, Randomized, Open-Label Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia and a CALR Mutation Previously Treated With Cytoreductive Therapy (EXCALIBUR-ET2)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2029-06-15","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05287126","publication_url":"https://clinicaltrials.gov/study/NCT05287126","title":"An Open-Label, Single-Arm Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of Etrasimod in Adolescent Participants With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2022-12-16","completion_date":"2029-06-16","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06763328","publication_url":"https://clinicaltrials.gov/study/NCT06763328","title":"Metformin (Dimethylbiguanide) and Insulin Resistance in Women Completing Neoadjuvant and/or Adjuvant Cytotoxic Treatment of Stage I-III Breast Cancer","has_exemption":false,"start_date":"2024-12-16","completion_date":"2029-06-16","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06914128","publication_url":"https://clinicaltrials.gov/study/NCT06914128","title":"A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of BAY 3713372, a Novel 2nd Generation PRMT5 Inhibitor, in Participants With MTAP-deleted Solid Tumors.","has_exemption":false,"start_date":"2025-03-21","completion_date":"2029-06-17","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04368702","publication_url":"https://clinicaltrials.gov/study/NCT04368702","title":"Clinical Onboard Utilization of Image Guided Radiation Therapy With Magnetic Resonance (CONFIRM): A Master Protocol","has_exemption":false,"start_date":"2021-05-01","completion_date":"2029-06-18","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07276399","publication_url":"https://clinicaltrials.gov/study/NCT07276399","title":"A Phase 3, Randomized, Open-Label, Multicenter Study of Amivantamab in Addition to Carboplatin and Pembrolizumab, Compared to Standard of Care Platinum and Pembrolizumab and 5-FU, in Participants With Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2025-12-03","completion_date":"2029-06-18","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03950232","publication_url":"https://clinicaltrials.gov/study/NCT03950232","title":"An Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2019-09-05","completion_date":"2029-06-19","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07013747","publication_url":"https://clinicaltrials.gov/study/NCT07013747","title":"A Phase 1/2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Participants With Mild Acne","has_exemption":false,"start_date":"2025-07-03","completion_date":"2029-06-19","has_results":false,"results_due":false,"sponsor_name":"Sanofi Pasteur, a Sanofi Company","sponsor_slug":"sanofi-pasteur-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07042581","publication_url":"https://clinicaltrials.gov/study/NCT07042581","title":"Evaluation of Revaree Plus in Women With Breast Cancer","has_exemption":false,"start_date":"2025-06-20","completion_date":"2029-06-20","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06477419","publication_url":"https://clinicaltrials.gov/study/NCT06477419","title":"Phase 2 Study of Sacituzumab Govitecan-hziy in Patients With Previously Treated Mesothelioma","has_exemption":false,"start_date":"2024-06-21","completion_date":"2029-06-21","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06852222","publication_url":"https://clinicaltrials.gov/study/NCT06852222","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Study of Bleximenib, Venetoclax and Azacitidine for the Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia Harboring KMT2A Rearrangements or NPM1 Mutations Who Are Ineligible for Intensive Chemotherapy","has_exemption":false,"start_date":"2025-06-04","completion_date":"2029-06-22","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06937229","publication_url":"https://clinicaltrials.gov/study/NCT06937229","title":"A Phase 3, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-3)","has_exemption":false,"start_date":"2025-12-02","completion_date":"2029-06-22","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07228273","publication_url":"https://clinicaltrials.gov/study/NCT07228273","title":"A Phase II Randomized Clinical Trial of Venetoclax Combined With FLAG IDA Induction and Consolidation Compared to Standard of Care for Newly Diagnosed Patients With Acute Myeloid Leukemia","has_exemption":false,"start_date":"2025-12-12","completion_date":"2029-06-24","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06044337","publication_url":"https://clinicaltrials.gov/study/NCT06044337","title":"A Multicenter, Open-Label, Single-Arm, Phase 3, Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of BIIB059 (Litifilimab) in Adult Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy","has_exemption":false,"start_date":"2023-10-03","completion_date":"2029-06-26","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07339423","publication_url":"https://clinicaltrials.gov/study/NCT07339423","title":"Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Obesity (AMAZE 1)","has_exemption":false,"start_date":"2026-02-24","completion_date":"2029-06-26","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05847569","publication_url":"https://clinicaltrials.gov/study/NCT05847569","title":"Phase II Trial for Evaluation of Alternate Doses and Dosing Schedules of Belantamab Mafodotin in Triple-Class Refractory Multiple Myeloma","has_exemption":false,"start_date":"2024-01-04","completion_date":"2029-06-29","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07207811","publication_url":"https://clinicaltrials.gov/study/NCT07207811","title":"CLEOPATTRA: Effects of NNC6019-0001 Versus Placebo on Cardiovascular Outcomes in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)","has_exemption":false,"start_date":"2025-10-02","completion_date":"2029-06-29","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06573970","publication_url":"https://clinicaltrials.gov/study/NCT06573970","title":"Atomoxetine Effect on Attention, Executive Function, and Quality of Life in Veterans With Posttraumatic Stress Disorder","has_exemption":false,"start_date":"2026-04-01","completion_date":"2029-06-29","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03887455","publication_url":"https://clinicaltrials.gov/study/NCT03887455","title":"A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease","has_exemption":false,"start_date":"2019-03-27","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Eisai Inc.","sponsor_slug":"eisai-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04120493","publication_url":"https://clinicaltrials.gov/study/NCT04120493","title":"A Phase 1/2, Randomized, Double-Blind, Sham Control and Open-Label Study to Explore Safety, Tolerability, and Efficacy Signals of Multiple Doses of Striatally-Administered rAAV5-miHTT Total Huntingtin Gene (HTT) Lowering Therapy (AMT-130) in Early Manifest Huntington's Disease","has_exemption":false,"start_date":"2019-09-06","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"UniQure Biopharma B.V.","sponsor_slug":"uniqure-biopharma-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04296903","publication_url":"https://clinicaltrials.gov/study/NCT04296903","title":"Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)","has_exemption":false,"start_date":"2020-05-31","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Apifix","sponsor_slug":"apifix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04404660","publication_url":"https://clinicaltrials.gov/study/NCT04404660","title":"An Open-Label, Multi-Centre, Phase Ib/II Study Evaluating the Safety and Efficacy of AUTO1, a CAR T Cell Treatment Targeting CD19, in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia","has_exemption":false,"start_date":"2020-06-03","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Autolus Limited","sponsor_slug":"autolus-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04298723","publication_url":"https://clinicaltrials.gov/study/NCT04298723","title":"Randomized Comparison of Interventional Closure of the Left Atrial Appendage Using a LAA Closure Device Versus Oral Anticoagulation Therapy in Patients With Non-valvular Atrial Fibrillation and Status Post Intracranial Bleeding.","has_exemption":false,"start_date":"2020-06-16","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Jena University Hospital","sponsor_slug":"jena-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04293562","publication_url":"https://clinicaltrials.gov/study/NCT04293562","title":"A Phase 3 Randomized Trial for Patients With De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 With GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients With FLT3 Mutations","has_exemption":false,"start_date":"2020-07-21","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04671667","publication_url":"https://clinicaltrials.gov/study/NCT04671667","title":"A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features","has_exemption":false,"start_date":"2021-04-27","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04889872","publication_url":"https://clinicaltrials.gov/study/NCT04889872","title":"The PROGRESS Trial: A Prospective, Randomized, Controlled Trial to Assess the Management of Moderate Aortic Stenosis by Clinical Surveillance or Transcatheter Aortic Valve Replacement","has_exemption":false,"start_date":"2021-10-12","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05268614","publication_url":"https://clinicaltrials.gov/study/NCT05268614","title":"Risk Adapted De-Intensification of Radio-Chemotherapy for Favorable Prognosis Oropharyngeal Squamous Cell Carcinoma Based on HPV Subtype and Plasma Circulating Free HPV DNA Level and Clearance Rate","has_exemption":false,"start_date":"2022-05-16","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04128189","publication_url":"https://clinicaltrials.gov/study/NCT04128189","title":"Safety and Immunogenicity of Shingrix in Renal Transplant Recipients","has_exemption":false,"start_date":"2023-03-02","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05650658","publication_url":"https://clinicaltrials.gov/study/NCT05650658","title":"Cardiac Resynchronization Therapy Using His/Left Bundle Branch Pacing vs Biventricular Pacing With a Left Ventricular Epicardial Lead in Patients With Heart Failure (HF) With Left Ventricular Ejection Fraction (LVEF)≤50% and With Either a Wide QRS Complex (>130 ms) or With/Anticipated >40% Pacing Randomized Clinical Trial","has_exemption":false,"start_date":"2023-09-13","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05609630","publication_url":"https://clinicaltrials.gov/study/NCT05609630","title":"A Multicenter, Randomized Open-Label Study to Assess the Efficacy, Safety, and Pharmacokinetics of Upadacitinib With a Tocilizumab Reference Arm in Subjects From 1 Year to Less Than 18 Years Old With Active Systemic Juvenile Idiopathic Arthritis","has_exemption":false,"start_date":"2023-10-02","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05863195","publication_url":"https://clinicaltrials.gov/study/NCT05863195","title":"A Randomized Phase III Study of Systemic Therapy With or Without Hepatic Arterial Infusion for Unresectable Colorectal Liver Metastases: The PUMP Trial","has_exemption":false,"start_date":"2023-10-19","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"ECOG-ACRIN Cancer Research Group","sponsor_slug":"ecog-acrin-cancer-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06060613","publication_url":"https://clinicaltrials.gov/study/NCT06060613","title":"A Phase 1/2, Open-Label Study to Investigate the Safety and Efficacy of Membrane Bound IL15 Expressing Tumor-Infiltrating Lymphocytes (OBX-115) In Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-10-25","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Obsidian Therapeutics, Inc.","sponsor_slug":"obsidian-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06245889","publication_url":"https://clinicaltrials.gov/study/NCT06245889","title":"A Pilot Study of Neoadjuvant Response-Adapted Chemotherapy With Pembrolizumab in Patients With Stage 2 and 3 Triple Negative Breast Cancer to Determine Early PET and Biomarker Dynamics","has_exemption":false,"start_date":"2024-05-01","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06408181","publication_url":"https://clinicaltrials.gov/study/NCT06408181","title":"APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia","has_exemption":false,"start_date":"2024-06-12","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05711667","publication_url":"https://clinicaltrials.gov/study/NCT05711667","title":"Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2024-07-11","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06315738","publication_url":"https://clinicaltrials.gov/study/NCT06315738","title":"Randomized, Controlled, Phase 1-2 Open Label Study of ST266 IV Administration to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)","has_exemption":false,"start_date":"2024-08-19","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Noveome Biotherapeutics, formerly Stemnion","sponsor_slug":"noveome-biotherapeutics-formerly-stemnion","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06486441","publication_url":"https://clinicaltrials.gov/study/NCT06486441","title":"A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy","has_exemption":false,"start_date":"2024-08-28","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06470243","publication_url":"https://clinicaltrials.gov/study/NCT06470243","title":"A Phase III Study of Cabazitaxel With or Without Carboplatin in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC), Stratified by Aggressive Variant Signature","has_exemption":false,"start_date":"2024-11-27","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06641414","publication_url":"https://clinicaltrials.gov/study/NCT06641414","title":"A Global Multicenter, Double-blind, Randomized, Registrational Phase 3 Study of Lisaftoclax (APG-2575) in Combination With Azacitidine (AZA) in Patients With Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS) (GLORA-4).","has_exemption":false,"start_date":"2025-01-22","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Ascentage Pharma Group Inc.","sponsor_slug":"ascentage-pharma-group-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06161974","publication_url":"https://clinicaltrials.gov/study/NCT06161974","title":"Phase 2 Study of Olutasidenib With Temozolomide as Maintenance Therapy in Pediatric and Young Adult Patients Newly Diagnosed With High-Grade Glioma (HGG), Including Diffuse Intrinsic Pontine Glioma (DIPG), Which Harbor IDH1 Mutations","has_exemption":false,"start_date":"2025-02-01","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Rigel Pharmaceuticals","sponsor_slug":"rigel-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06582875","publication_url":"https://clinicaltrials.gov/study/NCT06582875","title":"Advancing ADPKD Treatment With GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and Mechanism","has_exemption":false,"start_date":"2025-03-06","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06592586","publication_url":"https://clinicaltrials.gov/study/NCT06592586","title":"A Follow-up Trial to Assess the Persistence of the Immune Response to the Group B Streptococcus Vaccine (GBS-NN/NN2) After a Primary Vaccination of Healthy Pregnant Women, and to Assess Safety, Reactogenicity, and Immunogenicity of the GBS-NN/NN2 Vaccine When Administered During Follow-Up as a 1 Booster Dose During a New Pregnancy","has_exemption":false,"start_date":"2025-03-07","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Minervax ApS","sponsor_slug":"minervax-aps","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06291064","publication_url":"https://clinicaltrials.gov/study/NCT06291064","title":"TreAtment Response and Omic-Markers in Triple-Negative Breast CAncer Patients Receiving Standard of Care Chemotherapy (TARMAC)","has_exemption":false,"start_date":"2025-03-18","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06609369","publication_url":"https://clinicaltrials.gov/study/NCT06609369","title":"Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse","has_exemption":false,"start_date":"2025-04-21","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06953674","publication_url":"https://clinicaltrials.gov/study/NCT06953674","title":"Saline vs. Balanced Crystalloid in Traumatic Brain Injury","has_exemption":false,"start_date":"2025-06-01","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06721819","publication_url":"https://clinicaltrials.gov/study/NCT06721819","title":"The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-cardiac for Postoperative Delirium","has_exemption":false,"start_date":"2025-06-06","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06852469","publication_url":"https://clinicaltrials.gov/study/NCT06852469","title":"Individualized Computational Assessment of the Effects of GABA Receptor Modulation in Posttraumatic Stress Disorder","has_exemption":false,"start_date":"2025-07-01","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06940609","publication_url":"https://clinicaltrials.gov/study/NCT06940609","title":"Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation (MANIFEST)","has_exemption":false,"start_date":"2025-07-07","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of New Mexico","sponsor_slug":"university-of-new-mexico","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06943755","publication_url":"https://clinicaltrials.gov/study/NCT06943755","title":"A Phase 2/3, Multicenter, Randomized Open-Label Study of Zanzalintinib vs Everolimus in Participants With Previously Treated, Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors","has_exemption":false,"start_date":"2025-07-21","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Exelixis","sponsor_slug":"exelixis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217860","publication_url":"https://clinicaltrials.gov/study/NCT07217860","title":"A Multicenter, Long-term, Open-Label, Safety, Tolerability, and Efficacy Study of Azetukalner in Bipolar I or II Depression","has_exemption":false,"start_date":"2025-10-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Xenon Pharmaceuticals Inc.","sponsor_slug":"xenon-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07174310","publication_url":"https://clinicaltrials.gov/study/NCT07174310","title":"A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early-Stage Parkinson's Disease","has_exemption":false,"start_date":"2025-11-24","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07211958","publication_url":"https://clinicaltrials.gov/study/NCT07211958","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Newly Diagnosed AML With an NPM1 Mutation","has_exemption":false,"start_date":"2025-11-25","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Syndax Pharmaceuticals","sponsor_slug":"syndax-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07116395","publication_url":"https://clinicaltrials.gov/study/NCT07116395","title":"Outcomes of Tranexamic Acid With Anticoagulants in Orthopaedic Trauma Procedures: A Prospective Study","has_exemption":false,"start_date":"2026-01-01","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Arbi Nazarian, MD","sponsor_slug":"arbi-nazarian-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287995","publication_url":"https://clinicaltrials.gov/study/NCT07287995","title":"A Phase 1b/2 Study of ASP2998 as Monotherapy and in Combination With Standard Therapies in Participants With Locally Advanced Unresectable or Metastatic Solid Tumors","has_exemption":false,"start_date":"2026-02-05","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07077395","publication_url":"https://clinicaltrials.gov/study/NCT07077395","title":"Finding Links Between Hot flASHes and CardioVascular Disease","has_exemption":false,"start_date":"2026-03-01","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06907173","publication_url":"https://clinicaltrials.gov/study/NCT06907173","title":"Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)","has_exemption":false,"start_date":"2026-03-06","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Virginia","sponsor_slug":"university-of-virginia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07339111","publication_url":"https://clinicaltrials.gov/study/NCT07339111","title":"Randomized, Prospective, Double Blind, Multi-Center, Phase 3 Pivotal Clinical Trial to Compare Efficacy and Safety of CARTISTEM® and Surgical Comparator in Subjects With Knee Cartilage Lesions and Osteoarthritis","has_exemption":false,"start_date":"2026-03-11","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Medipost, Inc.","sponsor_slug":"medipost-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06882772","publication_url":"https://clinicaltrials.gov/study/NCT06882772","title":"Butyric Acid Supplementation for Gut Improvement After Cardiac Surgery in Kids, A Phase IIa Clinical Trial","has_exemption":false,"start_date":"2026-03-31","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298447","publication_url":"https://clinicaltrials.gov/study/NCT07298447","title":"An Open-Label Study of Donidalorsen in Pediatric Patients Age 2 to Less Than 12 Years Old With Hereditary Angioedema","has_exemption":false,"start_date":"2026-04-21","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Ionis Pharmaceuticals, Inc.","sponsor_slug":"ionis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07365332","publication_url":"https://clinicaltrials.gov/study/NCT07365332","title":"An Adaptive, 2-Part, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of IKT-001 in Pulmonary Arterial Hypertension (PAH)","has_exemption":false,"start_date":"2026-04-23","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Inhibikase Therapeutics","sponsor_slug":"inhibikase-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284602","publication_url":"https://clinicaltrials.gov/study/NCT07284602","title":"A Randomized, Double-Blind, Head-to-Head Phase 3 Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone at 52 Weeks in Adults With Idiopathic Pulmonary Fibrosis (SURPASS-IPF)","has_exemption":false,"start_date":"2026-04-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"PureTech","sponsor_slug":"puretech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07441876","publication_url":"https://clinicaltrials.gov/study/NCT07441876","title":"A Multicenter, Randomized, Operationally Seamless Phase 2/3 Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia","has_exemption":false,"start_date":"2026-04-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"BioMarin Pharmaceutical","sponsor_slug":"biomarin-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07020832","publication_url":"https://clinicaltrials.gov/study/NCT07020832","title":"A Phase 3, Randomized, Placebo-Controlled, Double-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation","has_exemption":false,"start_date":"2026-05-18","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Apellis Pharmaceuticals, Inc.","sponsor_slug":"apellis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06811545","publication_url":"https://clinicaltrials.gov/study/NCT06811545","title":"Exploring the Effects of Multi-Joint Neuromuscular Electrical Stimulation on Training Gait of Children With Cerebral Palsy","has_exemption":false,"start_date":"2026-05-31","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07290439","publication_url":"https://clinicaltrials.gov/study/NCT07290439","title":"Improving Maternal and Child Health Through Point-of-care STI Testing (MATCH-POINT)","has_exemption":false,"start_date":"2026-05-31","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07538804","publication_url":"https://clinicaltrials.gov/study/NCT07538804","title":"A Phase I/II, Open-Label, Multicenter Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Preliminary Efficacy of ANS02 in Participants With EGFR Mutation-Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2026-06-09","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Avistone Biotechnology Co., Ltd.","sponsor_slug":"avistone-biotechnology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07258290","publication_url":"https://clinicaltrials.gov/study/NCT07258290","title":"Safety and Clinical Performance of the Drug Eluting Resorbable Coronary Magnesium Scaffold System (Freesolve) in the Treatment of Subjects With de Novo Lesions in Native Coronary Arteries","has_exemption":false,"start_date":"2026-06-11","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Teleflex","sponsor_slug":"teleflex","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06960759","publication_url":"https://clinicaltrials.gov/study/NCT06960759","title":"Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough","has_exemption":false,"start_date":"2026-06-29","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Montana","sponsor_slug":"university-of-montana","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07277738","publication_url":"https://clinicaltrials.gov/study/NCT07277738","title":"Precision Supplemental Imaging in Women With Dense Breasts (PSID Trial)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07306364","publication_url":"https://clinicaltrials.gov/study/NCT07306364","title":"Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy Outcomes","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07452224","publication_url":"https://clinicaltrials.gov/study/NCT07452224","title":"An Open-Label Phase II Study of ILKN421H in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"iLeukon Therapeutics, Inc.","sponsor_slug":"ileukon-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07471139","publication_url":"https://clinicaltrials.gov/study/NCT07471139","title":"The SWITCH Trial: A Randomized Controlled Study of Apixaban Versus Vitamin K Antagonists in Patients With HeartMate 3 Left Ventricular Assist Devices","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07516444","publication_url":"https://clinicaltrials.gov/study/NCT07516444","title":"VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"VDyne, Inc.","sponsor_slug":"vdyne-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07592065","publication_url":"https://clinicaltrials.gov/study/NCT07592065","title":"Intraoperative Electrical Stimulation to Accelerate Functional Recovery of Peripheral Nerves After Decompressive Surgery","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07643012","publication_url":"https://clinicaltrials.gov/study/NCT07643012","title":"Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial Cancer: A Phase I/II Feasibility Study","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07104318","publication_url":"https://clinicaltrials.gov/study/NCT07104318","title":"Randomized Clinical Trial of Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans: \"VA Eradicate HP\"","has_exemption":false,"start_date":"2026-07-01","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07572175","publication_url":"https://clinicaltrials.gov/study/NCT07572175","title":"SPARTACUS Trial (Sotagliflozin as Prevention of Antracycline-Related Toxicity in Adipose, Cardiac and mUskuloSkeletal Tissues)","has_exemption":false,"start_date":"2026-07-31","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07651319","publication_url":"https://clinicaltrials.gov/study/NCT07651319","title":"A Phase Ib Clinical Trial, Using Interleukin-2 (IL-2) and Semaglutide in Patients With Alzheimer's Disease","has_exemption":false,"start_date":"2026-07-31","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06868238","publication_url":"https://clinicaltrials.gov/study/NCT06868238","title":"Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)","has_exemption":false,"start_date":"2026-08-31","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07655284","publication_url":"https://clinicaltrials.gov/study/NCT07655284","title":"STENT X Non-stent Genito-urinary Tract Reconstruction After Radical Cystectomy for Bladder Cancer - a Prospective, Randomized, Controlled and Multi Institutional Trial","has_exemption":false,"start_date":"2026-09-01","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07506863","publication_url":"https://clinicaltrials.gov/study/NCT07506863","title":"A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Subjects With α- or β- Transfusion-Dependent Thalassemia","has_exemption":false,"start_date":"2026-09-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Agios Pharmaceuticals, Inc.","sponsor_slug":"agios-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07219238","publication_url":"https://clinicaltrials.gov/study/NCT07219238","title":"A Phase 2/3, Multicenter, Open-Label, Non-Randomized Study to Evaluate Diagnostic Performance of GEH300079 (68Ga) Injection Positron-Emission Tomography (PET)/Computed Tomography (CT) for Detection of Peritoneal Carcinomatosis (PC) in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)","has_exemption":false,"start_date":"2026-10-31","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"GE Healthcare","sponsor_slug":"ge-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05976802","publication_url":"https://clinicaltrials.gov/study/NCT05976802","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam BID for 2 Weeks, Followed by QD for 4 Weeks, in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis","has_exemption":false,"start_date":"2027-06-30","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06236542","publication_url":"https://clinicaltrials.gov/study/NCT06236542","title":"NextGen Tracheostomy Toolkit: Integrating Augmented and Virtual Reality With Robotics to Improve Tracheostomy Care","has_exemption":false,"start_date":"2027-10-01","completion_date":"2029-06-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04071457","publication_url":"https://clinicaltrials.gov/study/NCT04071457","title":"S1803, Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients With Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)","has_exemption":false,"start_date":"2019-08-13","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"SWOG Cancer Research Network","sponsor_slug":"swog-cancer-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04558736","publication_url":"https://clinicaltrials.gov/study/NCT04558736","title":"Haploidentical Donor Hematopoietic Cell Transplantation for Patients With Severe Aplastic Anemia","has_exemption":false,"start_date":"2021-01-21","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06561425","publication_url":"https://clinicaltrials.gov/study/NCT06561425","title":"A Phase I/II, Multicenter Study Evaluating the Feasibility, Safety, and Efficacy of Point-of-care Manufactured GLPG5101 (19CP02) in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2022-03-09","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Lakefront Biotherapeutics NV","sponsor_slug":"lakefront-biotherapeutics-nv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06082063","publication_url":"https://clinicaltrials.gov/study/NCT06082063","title":"Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes","has_exemption":false,"start_date":"2024-07-01","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Steno Diabetes Center Copenhagen","sponsor_slug":"steno-diabetes-center-copenhagen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06364423","publication_url":"https://clinicaltrials.gov/study/NCT06364423","title":"Phase I/II Trial of Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for B-cell Leukemias","has_exemption":false,"start_date":"2024-09-03","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06328114","publication_url":"https://clinicaltrials.gov/study/NCT06328114","title":"Functional Magnetic Resonance Imaging (fMRI)-Guided Individualized Transcranial Magnetic Stimulation (TMS) for Cervical Dystonia","has_exemption":false,"start_date":"2024-12-17","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06657976","publication_url":"https://clinicaltrials.gov/study/NCT06657976","title":"Response to Exercise and Nitric Oxide in Peripheral Artery Disease: The RESIST PAD Trial","has_exemption":false,"start_date":"2025-01-23","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06650579","publication_url":"https://clinicaltrials.gov/study/NCT06650579","title":"Randomized Controlled Trial of Leuprolide Plus Abiraterone Acetate (AA) Versus Relugolix Plus AA for Advanced Prostate Cancer: The REVELUTION-2 Trial","has_exemption":false,"start_date":"2025-01-31","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02916810","publication_url":"https://clinicaltrials.gov/study/NCT02916810","title":"Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment","has_exemption":false,"start_date":"2025-02-01","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06427798","publication_url":"https://clinicaltrials.gov/study/NCT06427798","title":"Phase I/II Trial of Systemic Targeted Radioligand Therapy (TRT) With Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR Positive (SSTR+) Gastrointestinal (GI) Neuroendocrine Tumors (NET) and Pheochromocytoma/Paragangliomas Previously Treated With Systemic Radioligand Therapy","has_exemption":false,"start_date":"2025-02-07","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06837857","publication_url":"https://clinicaltrials.gov/study/NCT06837857","title":"Imaging, Cognition, and Opioids in Older Adults With Chronic Pain (I-COAP) Trial","has_exemption":false,"start_date":"2025-04-16","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06826859","publication_url":"https://clinicaltrials.gov/study/NCT06826859","title":"Dose Based Aspirin Pharmacokinetics and Pharmacodynamics in Pregnancy and Association With Pregnancy Outcomes","has_exemption":false,"start_date":"2025-06-26","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07013565","publication_url":"https://clinicaltrials.gov/study/NCT07013565","title":"NYMC623: A Comprehensive Risk-adapted Chemommunotherapy Protocol of Emerging Immunotherapies for Relapsed/Refractory Alk+ Anaplastic Large Cell Lymphoma (ACCELERATE)","has_exemption":false,"start_date":"2025-08-07","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07601100","publication_url":"https://clinicaltrials.gov/study/NCT07601100","title":"A Phase 1b/2 Study of the Combination Isatuximab, Iberdomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible or Not Intended for Upfront Transplant","has_exemption":false,"start_date":"2026-06-26","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05453851","publication_url":"https://clinicaltrials.gov/study/NCT05453851","title":"Total Pancreatectomy With Islet Cell Autotransplantation in Patients With Benign Pancreatic Neoplasms: A Pilot Study","has_exemption":false,"start_date":"2026-07-01","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"OHSU Knight Cancer Institute","sponsor_slug":"ohsu-knight-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07301346","publication_url":"https://clinicaltrials.gov/study/NCT07301346","title":"EASEE® System Pivotal Study for the United States of America","has_exemption":false,"start_date":"2026-07-01","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Precisis US, Inc.","sponsor_slug":"precisis-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07570862","publication_url":"https://clinicaltrials.gov/study/NCT07570862","title":"A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Refractory Moderate-to-Severe Systemic Lupus Erythematosus With Lupus Nephritis (RECLAIM-LN)","has_exemption":false,"start_date":"2026-07-01","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Fate Therapeutics","sponsor_slug":"fate-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07609927","publication_url":"https://clinicaltrials.gov/study/NCT07609927","title":"The TrAnscatheter Venous Valve Endoprosthesis Clinical Investigation of Safety and Effectiveness for the enVVe® System","has_exemption":false,"start_date":"2026-07-01","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Hancock Jaffe Laboratiores, Inc","sponsor_slug":"hancock-jaffe-laboratiores-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07602686","publication_url":"https://clinicaltrials.gov/study/NCT07602686","title":"MRI Evaluation of Local Anesthesia Administration","has_exemption":false,"start_date":"2026-07-15","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06811038","publication_url":"https://clinicaltrials.gov/study/NCT06811038","title":"Providing Nicotine Replacement Therapy to Enhance the Efficacy of a Smoking Cessation Smartphone App for Hispanic Adults","has_exemption":false,"start_date":"2026-08-15","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07655141","publication_url":"https://clinicaltrials.gov/study/NCT07655141","title":"A Phase 1/2 Trial Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of Subcutaneous ePGT121v1-LS in Combination With VRC07-523LS, Added to Standard Antiretroviral Therapy in Infants Living With HIV","has_exemption":false,"start_date":"2027-01-01","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Hospital Universitario 12 de Octubre","sponsor_slug":"hospital-universitario-12-de-octubre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07655128","publication_url":"https://clinicaltrials.gov/study/NCT07655128","title":"A Phase 1/2 Trial Evaluating the Safety, Pharmacokinetics, and Antiviral Activity of Subcutaneous ePGT121v1-LS, Added to Standard Antiretroviral Therapy in Infants Living With HIV","has_exemption":false,"start_date":"2027-01-01","completion_date":"2029-07-01","has_results":false,"results_due":false,"sponsor_name":"Hospital Universitario 12 de Octubre","sponsor_slug":"hospital-universitario-12-de-octubre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06717347","publication_url":"https://clinicaltrials.gov/study/NCT06717347","title":"A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Participants With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL) (waveLINE-010)","has_exemption":false,"start_date":"2025-01-27","completion_date":"2029-07-02","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221474","publication_url":"https://clinicaltrials.gov/study/NCT07221474","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of V940 in Combination With Pembrolizumab and Chemotherapy as First-Line Treatment for Participants With Metastatic Squamous NSCLC (INTerpath-013)","has_exemption":false,"start_date":"2025-12-12","completion_date":"2029-07-02","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07602855","publication_url":"https://clinicaltrials.gov/study/NCT07602855","title":"A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors","has_exemption":false,"start_date":"2026-09-08","completion_date":"2029-07-05","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284745","publication_url":"https://clinicaltrials.gov/study/NCT07284745","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Tolerability of KarXT + KarX-EC in Children and Adolescents (5 to 17 Years of Age) With Irritability Associated With Autism Spectrum Disorder","has_exemption":false,"start_date":"2026-09-11","completion_date":"2029-07-05","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06792825","publication_url":"https://clinicaltrials.gov/study/NCT06792825","title":"HM2023-43: A Phase 2 Trial of Tafasitamab in Combination With Lenalidomide+Rituximab in Treatment-naive Follicular Lymphoma and Marginal Zone Lymphoma","has_exemption":false,"start_date":"2025-08-07","completion_date":"2029-07-08","has_results":false,"results_due":false,"sponsor_name":"Masonic Cancer Center, University of Minnesota","sponsor_slug":"masonic-cancer-center-university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04606446","publication_url":"https://clinicaltrials.gov/study/NCT04606446","title":"A PHASE 1/2A DOSE ESCALATION AND EXPANSION STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETIC, PHARMACODYNAMIC, AND ANTI-TUMOR ACTIVITY OF PF-07248144 IN PARTICIPANTS WITH ADVANCED OR METASTATIC SOLID TUMORS","has_exemption":false,"start_date":"2020-11-16","completion_date":"2029-07-13","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05092958","publication_url":"https://clinicaltrials.gov/study/NCT05092958","title":"MAIN-CAV: Phase III Randomized Trial of Maintenance Cabozantinib and Avelumab vs Maintenance Avelumab After First-Line Platinum-Based Chemotherapy in Patients With Metastatic Urothelial Cancer","has_exemption":false,"start_date":"2022-06-03","completion_date":"2029-07-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07556939","publication_url":"https://clinicaltrials.gov/study/NCT07556939","title":"Light Utilization COX-Inhibitory Device Therapy for Infant Cardiac Arrest (LUTICA Study)","has_exemption":false,"start_date":"2026-07-15","completion_date":"2029-07-15","has_results":false,"results_due":false,"sponsor_name":"Mitovation, Inc","sponsor_slug":"mitovation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06254482","publication_url":"https://clinicaltrials.gov/study/NCT06254482","title":"A Phase 2b, Double-Blind, Randomized Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease","has_exemption":false,"start_date":"2023-08-25","completion_date":"2029-07-16","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07090863","publication_url":"https://clinicaltrials.gov/study/NCT07090863","title":"Additively (AM) Versus Subtractively (SM) Manufactured Implant Supported Fixed Dental Prostheses (iFDPs)","has_exemption":false,"start_date":"2025-07-30","completion_date":"2029-07-20","has_results":false,"results_due":false,"sponsor_name":"Harvard Medical School (HMS and HSDM)","sponsor_slug":"harvard-medical-school-hms-and-hsdm","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07498426","publication_url":"https://clinicaltrials.gov/study/NCT07498426","title":"A Phase III, Randomized, Placebo-controlled, Parallel Group, Double-blind Study to Evaluate the Efficacy and Safety of NIO752 in Participants With Progressive Supranuclear Palsy Followed by an Open Label Extension","has_exemption":false,"start_date":"2026-06-03","completion_date":"2029-07-20","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06528496","publication_url":"https://clinicaltrials.gov/study/NCT06528496","title":"N10: Reduced Therapy for High-Risk Neuroblastoma","has_exemption":false,"start_date":"2024-07-22","completion_date":"2029-07-22","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07567001","publication_url":"https://clinicaltrials.gov/study/NCT07567001","title":"Efficacy and Safety of NNC0487-0111 Compared to Placebo on Morbidity and Mortality in People With Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity","has_exemption":false,"start_date":"2026-05-11","completion_date":"2029-07-23","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06846281","publication_url":"https://clinicaltrials.gov/study/NCT06846281","title":"A Randomized, Open-label, Parallel-group, Non-inferiority Study Comparing Efficacy, Safety, and Tolerability of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis, Followed by Open-label Treatment With Remibrutinib","has_exemption":false,"start_date":"2025-07-23","completion_date":"2029-07-24","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07099391","publication_url":"https://clinicaltrials.gov/study/NCT07099391","title":"ALTITUDE - ALTernating Induction Therapies to Achieve Undetectable Disease Endpoints: A Phase 1/2 Alternating Dara-RVd/Teclistamab-RVd in Transplant Eligible Standard-risk Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2025-07-24","completion_date":"2029-07-24","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06287775","publication_url":"https://clinicaltrials.gov/study/NCT06287775","title":"A Phase I Dose Finding and Phase II Randomized Trial of Iadademstat Combined With Immune Checkpoint Inhibition Maintenance After Initial Chemoimmunotherapy in Patients With Extensive-Stage Small Cell Lung Cancer","has_exemption":false,"start_date":"2025-04-08","completion_date":"2029-07-25","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07419295","publication_url":"https://clinicaltrials.gov/study/NCT07419295","title":"A Phase 3, Randomized, Open-label Study of Sacituzumab Tirumotecan (MK-2870) Versus Investigator's Choice of Non-platinum Chemotherapy in Participants With Pretreated Locally Advanced/Metastatic Urothelial Carcinoma","has_exemption":false,"start_date":"2026-04-23","completion_date":"2029-07-27","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07444450","publication_url":"https://clinicaltrials.gov/study/NCT07444450","title":"A Phase 3, Randomized, Double-Blinded Study to Evaluate the Safety and Efficacy of Salanersen (BIIB115) After Onasemnogene Abeparvovec Treatment in Infants With Genetically Diagnosed Spinal Muscular Atrophy","has_exemption":false,"start_date":"2026-09-04","completion_date":"2029-07-27","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06157892","publication_url":"https://clinicaltrials.gov/study/NCT06157892","title":"A Phase 1b/2 Open-Label Study of Disitamab Vedotin in Combination With Other Anticancer Therapies in Solid Tumors","has_exemption":false,"start_date":"2024-05-20","completion_date":"2029-07-28","has_results":false,"results_due":false,"sponsor_name":"Seagen, a wholly owned subsidiary of Pfizer","sponsor_slug":"seagen-a-wholly-owned-subsidiary-of-pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06097364","publication_url":"https://clinicaltrials.gov/study/NCT06097364","title":"A Phase 3, Open-Label, Randomized Study to Compare the Efficacy and Safety of Odronextamab (REGN1979), an Anti-CD20x Anti-CD3 Bispecific Antibody, Combined With Chemotherapy Versus Rituximab Combined With Chemotherapy in Previously Untreated Participants With Follicular Lymphoma (OLYMPIA-2)","has_exemption":false,"start_date":"2023-11-14","completion_date":"2029-07-29","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06948318","publication_url":"https://clinicaltrials.gov/study/NCT06948318","title":"A Phase 3, Open-label, Multicenter Continuation Trial to Evaluate the Long-term Safety and Efficacy of Mezagitamab Subcutaneous Injection in Adults With Chronic Primary Immune Thrombocytopenia","has_exemption":false,"start_date":"2025-08-14","completion_date":"2029-07-29","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05844449","publication_url":"https://clinicaltrials.gov/study/NCT05844449","title":"A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor Triple Combination Therapy in Cystic Fibrosis Subjects 1 Year of Age and Older","has_exemption":false,"start_date":"2023-08-11","completion_date":"2029-07-30","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06981195","publication_url":"https://clinicaltrials.gov/study/NCT06981195","title":"Neurofunctional Phenotyping to Investigate the Role of the Orexin System at the Intersection of Opioid Use Disorder and Insomnia Among Women and Men Receiving Buprenorphine","has_exemption":false,"start_date":"2025-05-27","completion_date":"2029-07-30","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07464912","publication_url":"https://clinicaltrials.gov/study/NCT07464912","title":"A Multicentre, Randomised, Double-blind, Placebo-controlled, Adaptive Design Clinical Trial to Evaluate the Efficacy and Safety of TDI01 Suspension in the Treatment of Idiopathic Pulmonary Fibrosis (IPF)","has_exemption":false,"start_date":"2025-12-24","completion_date":"2029-07-30","has_results":false,"results_due":false,"sponsor_name":"Beijing Tide Pharmaceutical Co., Ltd","sponsor_slug":"beijing-tide-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07591610","publication_url":"https://clinicaltrials.gov/study/NCT07591610","title":"Perioperative High-flow Nasal Oxygen in Patients Undergoing Robotic Surgery: A Randomized Trial","has_exemption":false,"start_date":"2026-08-01","completion_date":"2029-07-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02307058","publication_url":"https://clinicaltrials.gov/study/NCT02307058","title":"A Phase II Randomized Trial of MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy - The Miami BLaStM Trial","has_exemption":false,"start_date":"2015-02-05","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02081326","publication_url":"https://clinicaltrials.gov/study/NCT02081326","title":"Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes","has_exemption":false,"start_date":"2015-06-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02756962","publication_url":"https://clinicaltrials.gov/study/NCT02756962","title":"Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance","has_exemption":false,"start_date":"2016-07-06","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02960022","publication_url":"https://clinicaltrials.gov/study/NCT02960022","title":"A Phase 2 Open-label Extension Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study","has_exemption":false,"start_date":"2016-12-22","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04349436","publication_url":"https://clinicaltrials.gov/study/NCT04349436","title":"An Open-Label, Multicenter, Phase 1B/2 Study of RP1 in Solid Organ and Hematopoietic Cell Transplant Recipients With Advanced Cutaneous Malignancies (ARTACUS)","has_exemption":false,"start_date":"2020-05-15","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Replimune Inc.","sponsor_slug":"replimune-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04684862","publication_url":"https://clinicaltrials.gov/study/NCT04684862","title":"Combined Infusion System to Deliver Chemotherapy Regionally to the Liver","has_exemption":false,"start_date":"2021-02-08","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Ronald DeMatteo, M.D.","sponsor_slug":"ronald-dematteo-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05203172","publication_url":"https://clinicaltrials.gov/study/NCT05203172","title":"ENCORAFENIB/BINIMETINIB MASTER PROTOCOL: AN OPEN-LABEL CONTINUATION STUDY FOR PARTICIPANTS CONTINUING FROM ENCORAFENIB/BINIMETINIB CLINICAL STUDIES","has_exemption":false,"start_date":"2022-07-05","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05481879","publication_url":"https://clinicaltrials.gov/study/NCT05481879","title":"A Randomized, Placebo-Controlled, Multiple Ascending Dose Study Assessing Safety, Tolerability, Pharmacodynamics, Efficacy, and Pharmacokinetics of DYNE-101 Administered to Participants With Myotonic Dystrophy Type 1","has_exemption":false,"start_date":"2022-09-05","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Dyne Therapeutics","sponsor_slug":"dyne-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05836987","publication_url":"https://clinicaltrials.gov/study/NCT05836987","title":"REACT-AF: Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation","has_exemption":false,"start_date":"2023-07-13","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05862272","publication_url":"https://clinicaltrials.gov/study/NCT05862272","title":"A Phase 3B, Single-Arm, Open-Label Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids or Moderate to Severe Pain Associated With Endometriosis","has_exemption":false,"start_date":"2023-08-14","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Sumitomo Pharma Switzerland GmbH","sponsor_slug":"sumitomo-pharma-switzerland-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06040255","publication_url":"https://clinicaltrials.gov/study/NCT06040255","title":"Focal Cerebral Arteriopathy Steroid Trial","has_exemption":false,"start_date":"2023-10-01","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05968898","publication_url":"https://clinicaltrials.gov/study/NCT05968898","title":"Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Cancer Risk Stratification of Pulmonary Nodules","has_exemption":false,"start_date":"2024-01-09","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04858009","publication_url":"https://clinicaltrials.gov/study/NCT04858009","title":"A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients With Pancreatic Cancer and Peritoneal Metastasis","has_exemption":false,"start_date":"2024-02-15","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06213649","publication_url":"https://clinicaltrials.gov/study/NCT06213649","title":"Parasitic Ulcer Treatment Trial","has_exemption":false,"start_date":"2024-07-01","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Jeremy Keenan, MD, MPH","sponsor_slug":"jeremy-keenan-md-mph","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06328777","publication_url":"https://clinicaltrials.gov/study/NCT06328777","title":"A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Systemic Sclerosis","has_exemption":false,"start_date":"2024-07-02","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Cabaletta Bio","sponsor_slug":"cabaletta-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06536413","publication_url":"https://clinicaltrials.gov/study/NCT06536413","title":"Phase IB/II Study Combining All-Trans Retinoic Acid (ATRA) With Carfilzomib Based Therapy in Plasma Cell Myeloma Patients Refractory to Carfilzomib","has_exemption":false,"start_date":"2024-07-29","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"The Methodist Hospital Research Institute","sponsor_slug":"the-methodist-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06171685","publication_url":"https://clinicaltrials.gov/study/NCT06171685","title":"MMRC Horizon One: A Phase II Randomized Adaptive Platform Trial Evaluating Novel Therapies in Relapsed or Refractory Multiple Myeloma (MMRC-099)","has_exemption":false,"start_date":"2024-11-17","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Multiple Myeloma Research Consortium","sponsor_slug":"multiple-myeloma-research-consortium","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06734351","publication_url":"https://clinicaltrials.gov/study/NCT06734351","title":"A Multicenter, Evaluator and Subject-blinded, Randomized, Comparator-controlled, Parallel-design Study to Evaluate the Safety and Effectiveness of NOA VOLUME Compared to JUVÉDERM® VOLUMA® XC for Improvement of Mid-face Volume","has_exemption":false,"start_date":"2024-12-16","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06846463","publication_url":"https://clinicaltrials.gov/study/NCT06846463","title":"Phase 2 Trial Utilizing Zanubrutinib in Patients With Diffuse Large B-cell Lymphoma and MYD88 L265P Mutations, CD79B Mutations, NOTCH1 Truncation or Who Are CD5+ by IHC.","has_exemption":false,"start_date":"2025-05-27","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07026279","publication_url":"https://clinicaltrials.gov/study/NCT07026279","title":"A Phase 1b/2a, Multicenter, Open Label Study of the Safety, Efficacy and Pharmacokinetics of Narmafotinib in Combination With Modified FOLFIRINOX in Pancreatic Cancer Patients","has_exemption":false,"start_date":"2025-08-18","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Amplia Therapeutics Limited","sponsor_slug":"amplia-therapeutics-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06274112","publication_url":"https://clinicaltrials.gov/study/NCT06274112","title":"Personalized Neuromodulation Targeting Dysregulated Motivational Responses Underlying Social Avoidance Behavior","has_exemption":false,"start_date":"2025-09-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Auburn University","sponsor_slug":"auburn-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07201207","publication_url":"https://clinicaltrials.gov/study/NCT07201207","title":"Single-center, Randomized, Controlled, Double Blinded, 24-month Trial to Compare Robotic-assisted (MAKO) and Manual Total Knee Arthroplasty for Primary Osteoarthritis With 10 Year Follow-up for Complications","has_exemption":false,"start_date":"2025-09-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Satakunta Central Hospital","sponsor_slug":"satakunta-central-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06325202","publication_url":"https://clinicaltrials.gov/study/NCT06325202","title":"Closed Loop and Education for Hypoglycemia Awareness Restoration (CLEAR), Conducted by the Impaired Awareness of Hypoglycemia Consortium (IAHC)","has_exemption":false,"start_date":"2025-10-03","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Milton S. Hershey Medical Center","sponsor_slug":"milton-s-hershey-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07247084","publication_url":"https://clinicaltrials.gov/study/NCT07247084","title":"A Phase 4 Multicenter, Randomized, Open-Label, Interventional Study With Pragmatic Elements Investigating the Effectiveness of Tirzepatide Once Weekly Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes in a Real-World Setting","has_exemption":false,"start_date":"2025-11-24","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221253","publication_url":"https://clinicaltrials.gov/study/NCT07221253","title":"Phase III, Randomized, Open-label, Global, Multicenter Study of Rilvegostomig or Durvalumab in Combination With Chemotherapy as a First-line Treatment for Patients With Advanced Biliary Tract Cancer (ARTEMIDE-Biliary02)","has_exemption":false,"start_date":"2025-12-04","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07227818","publication_url":"https://clinicaltrials.gov/study/NCT07227818","title":"A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Assess the Efficacy of NBI-1117568 in Preventing Relapse of the Symptoms of Schizophrenia and to Assess the Safety and Tolerability of NBI-1117568 in Adults With Schizophrenia","has_exemption":false,"start_date":"2025-12-16","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Neurocrine Biosciences","sponsor_slug":"neurocrine-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06994442","publication_url":"https://clinicaltrials.gov/study/NCT06994442","title":"Optimizing Pain Treatment in Children On Mechanical Ventilation","has_exemption":false,"start_date":"2025-12-29","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07157033","publication_url":"https://clinicaltrials.gov/study/NCT07157033","title":"A Phase 1/2a, Open Label, Dose-Escalation Study to Evaluate the Safety and Efficacy of XER-001 (Amifostibe for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment of Locally-Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2026-01-01","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Xerient Pharma","sponsor_slug":"xerient-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287449","publication_url":"https://clinicaltrials.gov/study/NCT07287449","title":"A Multi-Center, Prospective Historically Controlled Clinical Trial Comparing the Safety and Effectiveness of Triadyme-C to a Total Disc Replacement Control Cohort in the Treatment of Symptomatic Cervical Disc Disease (SCDD) at a Single Level","has_exemption":false,"start_date":"2026-01-05","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Dymicron","sponsor_slug":"dymicron","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06665074","publication_url":"https://clinicaltrials.gov/study/NCT06665074","title":"Inflammatory Challenge in Human Aggression.","has_exemption":false,"start_date":"2026-02-16","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07055581","publication_url":"https://clinicaltrials.gov/study/NCT07055581","title":"A Phase II Study of Durvalumab Combined With EP Prior to Chemoradiotherapy and Followed by Durvalumab as Consolidation for Patients With Limited-stage Small-cell Lung Cancer (CONCUR Study)","has_exemption":false,"start_date":"2026-02-24","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Qian Chu","sponsor_slug":"qian-chu","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285655","publication_url":"https://clinicaltrials.gov/study/NCT07285655","title":"A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (WHO Group 3)","has_exemption":false,"start_date":"2026-04-23","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Liquidia Technologies, Inc.","sponsor_slug":"liquidia-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07490067","publication_url":"https://clinicaltrials.gov/study/NCT07490067","title":"Personalizing Heart Failure Treatment With Genomics: A Clinical Trial to Understand the Mechanisms and Validate a Polygenic Risk Score for Beta-Blocker Response","has_exemption":false,"start_date":"2026-04-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07488676","publication_url":"https://clinicaltrials.gov/study/NCT07488676","title":"A Phase 1b/2 Open-label Study to Assess the Safety and Efficacy of ASP546C in Participants With CLDN18.2-expressing Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma, Pancreatic Adenocarcinoma or Other Solid Tumor Types","has_exemption":false,"start_date":"2026-05-04","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07323524","publication_url":"https://clinicaltrials.gov/study/NCT07323524","title":"Sodium-Glucose Co-Transporter-2 Inhibitors in Lupus Nephritis","has_exemption":false,"start_date":"2026-05-19","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07277309","publication_url":"https://clinicaltrials.gov/study/NCT07277309","title":"Promoting Recovery After Brain Injury Using Focused Ultrasound","has_exemption":false,"start_date":"2026-05-26","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07563881","publication_url":"https://clinicaltrials.gov/study/NCT07563881","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures","has_exemption":false,"start_date":"2026-06-05","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Rapport Therapeutics Inc.","sponsor_slug":"rapport-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02129751","publication_url":"https://clinicaltrials.gov/study/NCT02129751","title":"A Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder","has_exemption":false,"start_date":"2026-06-30","completion_date":"2029-07-31","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null}]}